| My Account | Subscribe | Contact Us | Donate |
Home
- The Top FREE iPhone Diabetes Apps
- 2010 Educational Resource Guide
- Ironman Jay
- Team Type 1 Cyclers Race Against Diabetes
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Insulin Articles
Study Says Lantus Lasts Longer Than Levemir
Dec 4, 2007
In an Italian study to compare once-daily injections of insulin glargine (Lantus) with once-daily injections of insulin detemir (Levemir), 24 patients with type 1 diabetes were treated for two weeks with either one or the other in a randomized double-blind study.
At the study's outset, the patients were injected with 0.35 units of insulin per kilogram, which comes to about 28.6 units for a 180-pound man. (See Dr. Bernstein's article about "long-acting" insulins for his opinion about giving experimental subjects high doses of long-acting insulin, "In My Opinion: There is No 24-Hour Basal Insulin")
Plasma glucose was clamped at 100 mg/dl for the 24 hours after the insulin injections. This means that for the 24 hours after the insulin injection, to prevent hypoglycemia, the patients were infused with just enough glucose to keep their blood sugar from dropping below 100 mg/dl.
With glargine, blood sugar remained at about 103 mg/dl for up to 24 hours. With detemir, things were fine for about sixteen hours, but then blood sugar began to increase progressively.
The glucose infusion rate was similar between the two insulins for twelve hours, after which it dropped more rapidly with detemir. Only about a third of the detemir subjects completed the study with blood sugar levels below 180 mg/dl.
The researchers, led by Francesca Porcellati, MD, concluded that glargine and detemir are similar for the first twelve hours, but that detemir begins to poop out during the second twelve hours.
Source: Diabetes Care, September 2007
Categories: Insulin, Lantus, Low Blood Sugar, Type 1 Issues
Facebook
MySpace 
Digg
You May Also Be Interested In...
Click Here To View Or Post Comments
14 comments -
Dec 4, 2007 -
Email to a Friend
Send a link to this page to your friends and colleagues.